Company

Kynexis

Biotechnology Research 18 employees

Employees: 18
Contacts: 1
Emails: 1
Phones: 1

www.kynexistx.com LinkedIn Crunchbase

Kynexis Overview

Website: www.kynexistx.com
Industry: Biotechnology Research
Employees: 18
Funding: 61.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

MBrace Therapeutics

About Kynexis

Kynexis is advancing precision therapeutics for brain diseases by taking a biomarker-based approach to advance a potential first-in-class treatment for cognitive impairment associated with schizophrenia (CIAS). By harnessing large data to identify and stratify patients based on the underlying causal human. biology of the disease, Kynexis is targeting KAT-II, a key enzyme in the kynurenine pathway. The company’s lead candidate, KYN-5356, is a first-in-class small molecule that is potent and highly selective for KAT-II.

Kynexis Contact Details

People in AeroLeads: 4
With contact data: 1
Email contacts: 1; 25.0% coverage
Phone contacts: 1; 25.0% coverage

Kynexis Org Chart

Sample employees and titles

Name	Title	Location	Contact
Raúl Martín-ruiz	Partner at Ysios Capital		View
Amy Archambault, Mba	Head of Finance at Kynexis	Auburn, New Hampshire, United States	Email Phone
Kees Been		United States	View
Heramb Chadchankar, Phd	Senior Director & Head of Translational		View